Impact Factor
3.92
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
4.75
913 total citations
h5-index
37
h5 depth signal
Cited share
89.9%
178 of 198
Total citations
913
Citation footprint
Metric signal
4.92
External metric anchor
Self-citation
1.1%
10 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
290
China
172
Italy
138
United Kingdom
95
Germany
64
Citing Fields of Research
Oncology
185
Clinical Laboratory Science
156
Genetics & Genomics
135
Lung Cancer
119
Noncoding RNA
97
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
2,543
Articles tracked across the journal lifetime
Indexed publication set
198
178 cited publications
Last 12 months
90
7.5 publications/month
Open access share
15.6%
14 OA publications in the last year
Leading citing country
United States
290 citing publications
Leading citing field
Oncology
185 citing publications
Latest tracked publication
18 October 2026
10 recent records available
Coverage & Indexing History
v1n1, May 2001-
v1n1, May 2001-
Active Coverage
Research Focus & Classification
Indexed Subjects
Oncology
Lung Cancer
Breast Cancer
Genetics & Genomics
Noncoding RNA
Neurodegenerative Disorders
Clinical Laboratory Science
Broad Categories
Molecular Biology
Lung Cancer
Noncoding RNA
Fungal Pathogenesis
Digestive Disorders
Genetics & Genomics
Musculoskeletal Disorders
Immunology
MeSH Descriptors
Diagnostic Techniques and Procedures
Genetics, Medical
Molecular Biology
Pharmacogenetics
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1080/14737159.2026.2747682
Open DOI
Emerging precision diagnostics in genitourinary cancers
Genitourinary tumors comprise distinct entities with different epidemiological background, molecular alterations, and clinical outcomes, underlining the need for precision diagnostics. Recent advances in molecular technologies have facil...
02
DOI 10.1080/14737159.2026.2749580
Open DOI
MRSA nasal PCR as a prevalence-dependent stewardship tool in hospitalized children: a structured review
Empiric anti-methicillin-resistant Staphylococcus aureus (MRSA) therapy is common in hospitalized children with severe pneumonia or suspected sepsis. MRSA nasal polymerase chain reaction (PCR) is increasingly used to support de-escalatio...
03
DOI 10.1080/14737159.2026.2745676
Open DOI
Systematic review of the impact of germline mutations from unrelated bone marrow donors on post-allogeneic transplantation
1. Patients with hematological disorders and cancers are often treated with allogeneic hematopoietic stem cell transplantation (HSCT), sometimes the only chance for a cure [1]. Over time, molecular...
04
05
DOI 10.1080/14737159.2026.2745670
Open DOI
Salivary nanobiosensors for oral diseases: from biomarker discovery to clinical translation in precision dentistry
1. The Global Burden of Disease (GBD) 2021 study demonstrates that severe periodontitis affects more than one billion people all over the world, and approximately 353 million individuals suffer fro...
06
DOI 10.1080/14737159.2026.2741059
Open DOI
Microfluidic approaches to next- generation sequencing library preparation: innovations, clinical integration and point-of-care settings
Next-generation sequencing (NGS) has revolutionized genomics by enabling high-throughput, cost-effective analysis of nucleic acids for both research and clinical applications. Library preparation remains a bottleneck in sequencing due to...
07
DOI 10.1080/14737159.2026.2741065
Open DOI
Integrated proteomics and metabolomics for predicting cardiometabolic risk in pregnant women living with HIV: current evidence and future directions
1.0. The global burden of HIV among women of reproductive age remains substantial. In 2023, women and girls accounted for approximately 21.1 million of the 39.9 million people living with HIV world...
08
DOI 10.1080/14737159.2026.2733191
Open DOI
Molecular events underlying sarcoma development and progression: the diagnostic relevance
1. Sarcomas are a very rare group of cancers (<1% of all solid malignancies) of mesenchymal origin, including over 100 histological subtypes [1] that arise from different tissues. The prognosis is ...
09
DOI 10.1080/14737159.2026.2733189
Open DOI
Nanotheranostics in orthopedic diseases: a critical review of molecular diagnostic-driven targeted therapeutics for personalized patient care
1. The musculoskeletal system comprises bones, joints, muscles, ligaments, and tendons. Orthopedic diseases (ODs) affect this system, causing pain, mobility impairment, and reduced quality of life ...
10
DOI 10.1080/14737159.2026.2733187
Open DOI
Culture-free genomics: a shift toward genome-wide applications in chagas disease and leishmaniasis
Bibliographical & Catalog Notes
Title from cover.
Vol. 1 complete in four issues.
Also issued online.